Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR
- PMID: 31441589
- DOI: 10.1002/ajmg.c.31736
Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR
Abstract
Megalencephaly (MEG) is a developmental abnormality of brain growth characterized by early onset, often progressive, brain overgrowth. Focal forms of megalencephaly associated with cortical dysplasia, such as hemimegalencephaly and focal cortical dysplasia, are common causes of focal intractable epilepsy in children. The increasing use of high throughput sequencing methods, including high depth sequencing to more accurately detect and quantify mosaic mutations, has allowed us to identify the molecular etiologies of many MEG syndromes, including most notably the PI3K-AKT-MTOR related MEG disorders. Thorough molecular and clinical characterization of affected individuals further allow us to derive preliminary genotype-phenotype correlations depending on the gene, mutation, level of mosaicism, and tissue distribution. Our review of published data on these disorders so far shows that mildly activating variants (that are typically constitutional or germline) are associated with diffuse megalencephaly with intellectual disability and/or autism spectrum disorder; moderately activating variants (that are typically high-level mosaic) are associated with megalencephaly with pigmentary abnormalities of the skin; and strongly activating variants (that are usually very low-level mosaic) are associated with focal brain malformations including hemimegalencephaly and focal cortical dysplasia. Accurate molecular diagnosis of these disorders is undoubtedly crucial to more optimally treat children with these disorders using PI3K-AKT-MTOR pathway inhibitors.
Keywords: AKT3; MTOR; PIK3CA; PIK3R2; megalencephaly.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- Alcantara, D., Timms, A. E., Gripp, K., Baker, L., Park, K., Collins, S., … Mirzaa, G. M. (2017). Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly. Brain, 140(10), 2610-2622.
-
- Assogba, K., Ferlazzo, E., Striano, P., Calarese, T., Villeneuve, N., Ivanov, I., … Genton, P. (2010). Heterogeneous seizure manifestations in Hypomelanosis of Ito: Report of four new cases and review of the literature. Neurological Sciences, 31(1), 9-16.
-
- Auriemma, A., Agostinis, C., Bianchi, P., Bellan, C., Salvoni, L., Manara, O., & Colombo, A. (2000). Hemimegalencephaly in hypomelanosis of Ito: Early sonographic pattern and peculiar MR findings in a newborn. European Journal of Ultrasound, 12(1), 61-67.
-
- Battistella, P. A., Peserico, A., Bertoli, P., Drigo, P., Laverda, A. M., & Casara, G. L. (1990). Hypomelanosis of Ito and hemimegalencephaly. Child's Nervous System, 6(7), 421-423.
-
- Blumcke, I., Thom, M., Aronica, E., Armstrong, D. D., Vinters, H. V., Palmini, A., … Spreafico, R. (2011). The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia, 52(1), 158-174.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
